These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18367111)

  • 1. Exploring causes for declining prostate cancer mortality rates in the United States.
    Colli JL; Amling CL
    Urol Oncol; 2008; 26(6):627-33. PubMed ID: 18367111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in prostate cancer mortality among black men and white men in the United States.
    Chu KC; Tarone RE; Freeman HP
    Cancer; 2003 Mar; 97(6):1507-16. PubMed ID: 12627516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary prostate cancer screening outcomes by race in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Screening Trial.
    Miller EA; Pinsky PF; Black A; Andriole GL; Pierre-Victor D
    Prostate; 2018 Aug; 78(11):830-838. PubMed ID: 29667217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Geographical, temporal and racial disparities in late-stage prostate cancer incidence across Florida: a multiscale joinpoint regression analysis.
    Goovaerts P; Xiao H
    Int J Health Geogr; 2011 Dec; 10():63. PubMed ID: 22142274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in the Incidence of Fatal Prostate Cancer in the United States by Race.
    Kelly SP; Rosenberg PS; Anderson WF; Andreotti G; Younes N; Cleary SD; Cook MB
    Eur Urol; 2017 Feb; 71(2):195-201. PubMed ID: 27476048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High cholesterol levels are associated with reduced prostate cancer mortality rates during periods of high but not low statin use in the United States.
    Colli JL; Amling CL
    Urol Oncol; 2009; 27(2):170-3. PubMed ID: 18367120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer incidence and mortality rates among white and black men.
    Merrill RM; Brawley OW
    Epidemiology; 1997 Mar; 8(2):126-31. PubMed ID: 9229202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultraviolet index and racial differences in prostate cancer incidence and mortality.
    Taksler GB; Cutler DM; Giovannucci E; Smith MR; Keating NL
    Cancer; 2013 Sep; 119(17):3195-203. PubMed ID: 23744754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of stage-specific survival rates in assessing recent declines in prostate cancer mortality rates.
    Tarone RE; Chu KC; Brawley OW
    Epidemiology; 2000 Mar; 11(2):167-70. PubMed ID: 11021614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in palatine tonsillar cancer incidence and mortality rates in the United States.
    Golas SM
    Community Dent Oral Epidemiol; 2007 Apr; 35(2):98-108. PubMed ID: 17331151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of African-American ethnic background with survival in men with metastatic prostate cancer.
    Thompson I; Tangen C; Tolcher A; Crawford E; Eisenberger M; Moinpour C
    J Natl Cancer Inst; 2001 Feb; 93(3):219-25. PubMed ID: 11158191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer mortality in the United States by cohort year of birth, 1865-1940.
    Hsing AW; Devesa SS
    Cancer Epidemiol Biomarkers Prev; 1994; 3(7):527-30. PubMed ID: 7827581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of PSA screening on prostate cancer mortality and overdiagnosis of prostate cancer in the United States.
    Howrey BT; Kuo YF; Lin YL; Goodwin JS
    J Gerontol A Biol Sci Med Sci; 2013 Jan; 68(1):56-61. PubMed ID: 22562961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Geographic patterns of prostate cancer mortality and variations in access to medical care in the United States.
    Jemal A; Ward E; Wu X; Martin HJ; McLaughlin CC; Thun MJ
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):590-5. PubMed ID: 15767335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer incidence and mortality rates and trends in the United States and Canada.
    McDavid K; Lee J; Fulton JP; Tonita J; Thompson TD
    Public Health Rep; 2004; 119(2):174-86. PubMed ID: 15192905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is PSA related to serum cholesterol and does the relationship differ between black and white men?
    Zapata D; Howard LE; Allott EH; Hamilton RJ; Goldberg K; Freedland SJ
    Prostate; 2015 Dec; 75(16):1877-85. PubMed ID: 26332663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of Prostate Specific Antigen Screening among Black Men in the United States in the Contemporary Era.
    Sammon JD; Dalela D; Abdollah F; Choueiri TK; Han PK; Hansen M; Nguyen PL; Sood A; Menon M; Trinh QD
    J Urol; 2016 Apr; 195(4 Pt 1):913-8. PubMed ID: 26598427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations.
    Jemal A; Fedewa SA; Ma J; Siegel R; Lin CC; Brawley O; Ward EM
    JAMA; 2015 Nov; 314(19):2054-61. PubMed ID: 26575061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why is the prostate cancer death rate declining in the United States?
    Mettlin CJ; Murphy GP
    Cancer; 1998 Jan; 82(2):249-51. PubMed ID: 9445178
    [No Abstract]   [Full Text] [Related]  

  • 20. Cancer surveillance series: interpreting trends in prostate cancer--part III: Quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality.
    Etzioni R; Legler JM; Feuer EJ; Merrill RM; Cronin KA; Hankey BF
    J Natl Cancer Inst; 1999 Jun; 91(12):1033-9. PubMed ID: 10379966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.